5,065 reports of this reaction
5.8% of all WARFARIN SODIUM reports
#1 most reported adverse reaction
INTERNATIONAL NORMALISED RATIO INCREASED is the #1 most commonly reported adverse reaction for WARFARIN SODIUM, manufactured by Upsher-Smith Laboratories, LLC. There are 5,065 FDA adverse event reports linking WARFARIN SODIUM to INTERNATIONAL NORMALISED RATIO INCREASED. This represents approximately 5.8% of all 87,043 adverse event reports for this drug.
WARFARIN SODIUM has an overall safety score of 92 out of 100. Patients taking WARFARIN SODIUM who experience international normalised ratio increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTERNATIONAL NORMALISED RATIO INCREASED is moderately reported among WARFARIN SODIUM users, representing a notable but not dominant share of adverse events.
In addition to international normalised ratio increased, the following adverse reactions have been reported for WARFARIN SODIUM:
The following drugs have also been linked to international normalised ratio increased in FDA adverse event reports:
INTERNATIONAL NORMALISED RATIO INCREASED has been reported as an adverse event in 5,065 FDA reports for WARFARIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTERNATIONAL NORMALISED RATIO INCREASED accounts for approximately 5.8% of all adverse event reports for WARFARIN SODIUM, making it one of the most commonly reported side effect.
If you experience international normalised ratio increased while taking WARFARIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.